Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Medibyt Receives FDA 510(k) Clearance for CPETWise, Advancing Cardiopulmonary ...

1 September 2026 · By · Wire by Fusion42

Published

1 September 2026

Topic

opportunities

◆ Sectors

Digital Health

◆ Geography

United States

◆ Source

Read at prnewswire.com →

◆ Verified

Fusion42 · 1 September 2026 · Fusion42 review

Medibyt received FDA 510(k) clearance for its CPETWise platform, enabling U.S. commercialisation to advance automated cardiopulmonary exercise test analysis with AI-driven workflow improvements.

This Wire brief sits within Fusion42's coverage of Digital Health, and 5 sources have reported it between 1 Sep 2026 and 4 Sep 2026.

◆ ◆ The Wire takeaway

You can now target U.S. cardiopulmonary diagnostics with a cleared automated test analysis tool. This clearance opens doors to partnerships and regional leads for AI-driven clinical platforms in heart and lung health.

◆ Coverage

5 sources · first reported 1 Sep 2026 · latest 4 Sep 2026

◆ Related on Wire

◆ Topics

Digital Healthfda-clearancecardiopulmonarydigital-healthautomationclinical-diagnostics